Alpha 2.0
Login Register
» Articles » PMID: 28802144

The Effect of CYP2C19 Genetic Polymorphism and Non-genetic Factors on Clopidogrel Platelets Inhibition in East Asian Coronary Artery Disease Patients

Overview
Journal Thromb Res
Date 2017 Aug 13
PMID 28802144
Citations 8
Authors
Arwa M Amin
Lim Sheau Chin
Dzul Azri Mohamed Noor
Hamza Mostafa
Muhamad Ali S K Abdul Kader
Yuen Kah Hay
Baharudin Ibrahim
Affiliations
Soon will be listed here.
Citing Articles

METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients.

Tan Q, Yang L, Yuan S, Zheng D, Lin Y, Chen K Open Med (Wars). 2024; 19(1):20240899.

PMID: 38463525 PMC: 10921439. DOI: 10.1515/med-2024-0899.

The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI): Affectability of Rapid Genetic Testing.

Akkaif M, Daud N, Mohamed Noor D, Shaaban A, Kader M, Ibrahim B Cardiovasc Drugs Ther. 2024; .

PMID: 38224415 DOI: 10.1007/s10557-024-07544-6.

The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention.

Giantini A, Timan I, Dharma R, Sukmawan R, Setiabudy R, Alwi I Front Cardiovasc Med. 2023; 9:1027892.

PMID: 36843628 PMC: 9944402. DOI: 10.3389/fcvm.2022.1027892.

The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD).

Akkaif M, Daud N, Shaaban A, Ng M, Kader M, Mohamed Noor D Molecules. 2021; 26(7).

PMID: 33915807 PMC: 8036376. DOI: 10.3390/molecules26071987.

*2 Polymorphism Related to Clopidogrel Resistance in Patients With Coronary Heart Disease, Especially in the Asian Population: A Systematic Review and Meta-Analysis.

Sun Y, Lu Q, Tao X, Cheng B, Yang G Front Genet. 2021; 11:576046.

PMID: 33414804 PMC: 7783419. DOI: 10.3389/fgene.2020.576046.